The delivery of synthesis targets within drug discovery often involves chemists from different organizations. Engaging contract research organization (CRO) partners ...
Chemistry teams working in small molecule discovery follow an iterative Design-Make-Test-Analyze (DMTA) cycle to design and optimize new therapeutics. Companies ...
Torx Design™ is a cloud-based platform that provides a central location to capture and share information about molecules, hypotheses and ...
Increased demands in pharmaceutical R&D have led to an increase in outsourcing The journey of a new drug from hypothesis ...
The importance of communication in drug discovery Every drug discovery program can be described using the iterative Design-Make-Test-Analyze (DMTA) workflow. ...
Design-Make-Test-Analyze Irrespective of the therapeutic area or target pathway, all small molecule discovery teams repeat a common workflow to optimize ...
Coordinating new molecule chemistry through the Design-Make-Test-Analyze (DMTA) cycle has never been more important or more challenging. Each project in ...
We are delighted to announce the launch of Torx™, a new platform for small molecule discovery chemistry.
Cambridge, UK – 22 April 2020 – Torx Software announces the launch of Torx™, a new web-based platform for small ...
Torx accelerates every part of your Design-Make-Test-Analyze workflow. The unique modular approach provides dedicated interfaces to enhance each stage in ...
The following presentations and poster were delivered at the 258th ACS National Meeting in San Diego in August 2019.
Cambridge, UK – 6 August 2019 – Cresset and Elixir to preview Torx™ at key European events for medicinal chemists.